PanGenomic Health Subsidiary Signs Rental Agreement with Psy Integrated Health, Makes Progress Towards Development of Joint Testing Facility

by PanGenomic | Feb 2, 2023 | Business Update

‍ VANCOUVER, BC, Feb. 2, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce that, further to the announcement made on January 26, 2023, its subsidiary, MUJN Diagnostics Inc....

PanGenomic Health Announces Intention to Dual List on the UK Aquis Stock Exchange Growth Market

by PanGenomic | Jan 31, 2023 | Business Update

‍ VANCOUVER, BC, Jan. 31, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce its intention to apply for admission to trading on the Aquis Stock Exchange Growth Market...

Fobi Announces The Commercial Launch Of PulseIR With First Client, Digital Health Platform PanGenomic Health Inc.

by PanGenomic | Jan 30, 2023 | Business Update

‍ VANCOUVER, BC, Jan. 30, 2023 (GLOBE NEWSWIRE) — Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the “Company” or “Fobi”), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to announce the commercial launch of its...

PanGenomic Health Subsidiary Signs Non-Binding MoU with Psy Integrated Health for Diagnostic Testing Joint Venture

by PanGenomic | Jan 23, 2023 | Business Update

‍Vancouver, British Columbia, Canada, January 26, 2023 – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce its subsidiary, MUJN Diagnostics Inc. (formerly named PlantGx Diagnostics Corp.)(“MUJN...

PanGenomic Health’s Nara Plant Library is Now Available. Nara App also Supports New FTC Regulatory Guideline for Science-Backed Information about Natural Remedy Alternatives to Pharmaceutical Drugs

by PanGenomic | Jan 23, 2023 | Business Update

VANCOUVER, BC, Jan. 23, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app as a resource to provide science-backed...

PanGenomic Health Announces Soft Launch of NARA Personalized DNA Reports and Closing of its Non-Brokered Private Placement Offering

by PanGenomic | Jan 20, 2023 | Business Update

NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC, Jan. 20, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce the soft launch of...